BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Purchases 1,796,176.25 in Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. acquired 130,631 shares of BlackRock Health Sciences Term Trust stock in a transaction on Friday, November 3rd. The shares were bought at an average price of 13.75 per share, for a total transaction of 1,796,176.25. Following the completion of the purchase, the insider now directly owns 11,898,108 shares in the company, valued at 163,598,985. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Monday, November 6th, Saba Capital Management, L.P. acquired 221,000 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 13.78 per share, for a total transaction of 3,045,380.00.
• On Wednesday, November 1st, Saba Capital Management, L.P. acquired 57,124 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 13.15 per share, for a total transaction of 751,180.60.
• On Monday, October 30th, Saba Capital Management, L.P. acquired 91,473 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 13.03 per share, for a total transaction of 1,191,893.19.
• On Thursday, October 26th, Saba Capital Management, L.P. acquired 201,054 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 13.27 per share, for a total transaction of 2,667,986.58.
• On Tuesday, October 24th, Saba Capital Management, L.P. acquired 26,660 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 13.50 per share, for a total transaction of 359,910.00.

BlackRock Health Sciences Term Trust Stock Performance

BlackRock Health Sciences Term Trust stock opened at 13.75 on Tuesday. The firm’s 50-day moving average is 14.28 and its 200-day moving average is 15.48. BlackRock Health Sciences Term Trust has a 1 year low of 12.93 and a 1 year high of 17.05.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th will be given a $0.0927 dividend. The ex-dividend date is Tuesday, November 14th. This represents a $1.11 dividend on an annualized basis and a dividend yield of 8.09%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Bank of America Corp DE lifted its position in shares of BlackRock Health Sciences Term Trust by 0.9% in the 1st quarter. Bank of America Corp DE now owns 2,551,535 shares of the company’s stock worth $42,636,000 after buying an additional 21,553 shares during the last quarter. UBS Group AG lifted its position in shares of BlackRock Health Sciences Term Trust by 2.6% in the 1st quarter. UBS Group AG now owns 2,180,744 shares of the company’s stock worth $36,440,000 after buying an additional 54,442 shares during the last quarter. Karpus Management Inc. lifted its position in shares of BlackRock Health Sciences Term Trust by 4.1% in the 2nd quarter. Karpus Management Inc. now owns 856,797 shares of the company’s stock worth $14,069,000 after buying an additional 33,677 shares during the last quarter. Logan Stone Capital LLC lifted its position in shares of BlackRock Health Sciences Term Trust by 33.2% in the 4th quarter. Logan Stone Capital LLC now owns 338,129 shares of the company’s stock worth $5,217,000 after buying an additional 84,373 shares during the last quarter. Finally, LPL Financial LLC increased its holdings in shares of BlackRock Health Sciences Term Trust by 27.8% in the 2nd quarter. LPL Financial LLC now owns 273,434 shares of the company’s stock worth $4,490,000 after acquiring an additional 59,446 shares during the period.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.